Apogee Therapeutics Inc (APGE) PT Lowered to $116 at Deutsche Bank
Tweet
Share
E-mailGet Alerts APGE Hot Sheet
Price: $134.55 +0.07%
Rating Summary:
5 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Deutsche Bank analyst David Hoang lowered the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $116.00 (from $118.00) while maintaining a Buy rating.
You May Also Be Interested In
- Apogee Therapeutics Inc (APGE) PT Raised to $135 at Truist Securities
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
